Acronym EXOpro Title Development of a scalable manufacturing process for therapeutic human mesenchymal stem/stromal cell-derived exosomes Summary

The goal of EXOpro is to develop a fully controlled manufacturing process for the production and purification of an effective, safe and fully characterized MSC-derived exosome-based product.

Project webpage Start year 01/10/2018 End year 30/09/2021 ID PTDC/EQU-EQU/31651/2017 iBB Role Coordinator iBB Budget 231 679,22 € Research Group SCERG PI Ana Fernandes Project Partners USP-Universidade de São Paulo Status Completed Funding FAPESP/FCT